Italy - Re-Imbursed Pharmaceutical Market
Since 2014, Italy Re-Imbursed Pharmaceutical Market jumped by 1.6points year on year. In 2019, the country was ranked number 16 comparing other countries in Re-Imbursed Pharmaceutical Market with 9.4 Percent of Generics in Value. Italy is overtaken by Belgium, which was ranked number 15 at 13.9 Percent of Generics in Value and is followed by Luxembourg with 5.8 Percent of Generics in Value. Austria topped the ranking with 52.2 Percent of Generics in Value in 2019, that is +2.8points compared to 2018. United Kingdom, Turkey and New Zealand respectively ranked number 2, 3 and 4 in this ranking. Denmark recorded the best 5 years average growth at +6.9points per year, while Slovakia was the worst growing country at -7.8points per year.
Loading...
| Date | Percent of Generics in Value |
|---|---|
| 2019 | 9.40 |
| 2018 | 9.30 |
| 2017 | 8.70 |
| 2016 | 7.90 |
| 2015 | 7.90 |
How does Italy rank in Re-Imbursed Pharmaceutical Market?
| # | 17 Countries | Percent of Generics in Value | Last | YoY | 5‑years CAGR | ||
|---|---|---|---|---|---|---|---|
| 1 |
#1
Austria
|
52.20 % | 2019 | +2.8 % | +2.2 % | View data | |
| 2 |
#2
United Kingdom
|
38.50 % | 2019 | +2.1 % | +2.6 % | View data | |
| 15 |
#15
Belgium
|
13.90 % | 2019 | +4.5 % | +0.9 % | View data | |
| 16 |
#16
Italy
|
9.40 % | 2019 | +1.1 % | +1.6 % | View data | |
| 17 |
#17
Luxembourg
|
5.80 % | 2019 | +0.0 % | +4.3 % | View data | |